Cargando…

Serum TARC Levels in Patients with Systemic Sclerosis: Clinical Association with Interstitial Lung Disease

Systemic sclerosis (SSc) is a multisystem fibrotic disorder with autoimmune background. Accumulating evidence has highlighted the importance of T helper (Th) 2 cells in the pathogenesis of SSc and its complications. Because thymus and activation-regulated chemokine (TARC) is a potent chemoattractant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuzumi, Ai, Yoshizaki, Ayumi, Ebata, Satoshi, Fukasawa, Takemichi, Yoshizaki-Ogawa, Asako, Asano, Yoshihide, Oba, Koji, Sato, Shinichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915627/ https://www.ncbi.nlm.nih.gov/pubmed/33572144 http://dx.doi.org/10.3390/jcm10040660

Ejemplares similares

Increased Red Blood Cell Distribution Width in the First Year after Diagnosis Predicts Worsening of Systemic Sclerosis-Associated Interstitial Lung Disease at 5 Years: A Pilot Study
por: Ebata, Satoshi, et al.
Publicado: (2021)

Serum Calponin 3 Levels in Patients with Systemic Sclerosis: Possible Association with Skin Sclerosis and Arthralgia
por: Kotani, Hirohito, et al.
Publicado: (2021)

Skin thickness score as a surrogate marker of organ involvements in systemic sclerosis: a retrospective observational study
por: Matsuda, Kazuki M., et al.
Publicado: (2019)

Involvement of B cells in the development of systemic sclerosis
por: Yoshizaki, Ayumi, et al.
Publicado: (2022)

Serum C-X-C Chemokine Ligand 1 Levels in Patients with Systemic Sclerosis: Relationship of Clinical and Laboratory Observations to Anti-CD20 Monoclonal Antibody Administration
por: Kawanabe, Ruriko, et al.
Publicado: (2022)

Interleukin-31 promotes fibrosis and T helper 2 polarization in systemic sclerosis
por: Kuzumi, Ai, et al.
Publicado: (2021)

Single-cell-level protein analysis revealing the roles of autoantigen-reactive B lymphocytes in autoimmune disease and the murine model
por: Fukasawa, Takemichi, et al.
Publicado: (2021)

New Era in Systemic Sclerosis Treatment: Recently Approved Therapeutics
por: Ebata, Satoshi, et al.
Publicado: (2022)

Pharmacotherapy of Itch—Antihistamines and Histamine Receptors as G Protein-Coupled Receptors
por: Fukasawa, Takemichi, et al.
Publicado: (2022)

Involvement of Molecular Mechanisms between T/B Cells and IL-23: From Palmoplantar Pustulosis to Autoimmune Diseases
por: Fukasawa, Takemichi, et al.
Publicado: (2022)

The Role of Mammalian STK38 in DNA Damage Response and Targeting for Radio-Sensitization
por: Fukasawa, Takemichi, et al.
Publicado: (2023)

Autoantibody Landscape Revealed by Wet Protein Array: Sum of Autoantibody Levels Reflects Disease Status
por: Matsuda, Kazuki M., et al.
Publicado: (2022)

The Autoantibody Array Assay: A Novel Autoantibody Detection Method
por: Norimatsu, Yuta, et al.
Publicado: (2023)

The optimal use of tildrakizumab in the elderly via improvement of Treg function and its preventive effect of psoriatic arthritis
por: Fukasawa, Takemichi, et al.
Publicado: (2023)

Comprehensive autoantibody profiling in systemic autoimmunity by a highly-sensitive multiplex protein array
por: Kuzumi, Ai, et al.
Publicado: (2023)

Rapid improvement of systemic sclerosis-associated intestinal pseudo-obstruction with intravenous immunoglobulin administration
por: Matsuda, Kazuki M, et al.
Publicado: (2023)

Increased Serum Levels of Tumor Necrosis Factor-like Ligand 1A in Atopic Dermatitis
por: Hisamoto, Teruyoshi, et al.
Publicado: (2023)

Abnormal B Lymphocyte Activation and Function in Systemic Sclerosis
por: Yoshizaki, Ayumi, et al.
Publicado: (2015)

Prevention of calpain-dependent degradation of STK38 by MEKK2-mediated phosphorylation
por: Enomoto, Atsushi, et al.
Publicado: (2019)

Endothelial CCR6 expression due to FLI1 deficiency contributes to vasculopathy associated with systemic sclerosis
por: Ikawa, Tetsuya, et al.
Publicado: (2021)

An orally-active adiponectin receptor agonist mitigates cutaneous fibrosis, inflammation and microvascular pathology in a murine model of systemic sclerosis
por: Yamashita, Takashi, et al.
Publicado: (2018)

TOF and TARC
Publicado: (2000)

Clinical Risk Factors for Dysphagia and Esophageal Dysmotility in Systemic Sclerosis
por: Hara, Mariko, et al.
Publicado: (2023)

Fli1 deficiency suppresses RALDH1 activity of dermal dendritic cells and related induction of regulatory T cells: a possible role in scleroderma
por: Miura, Shunsuke, et al.
Publicado: (2021)

Memorandum: Completion of the TARC experiment
por: CERN. Geneva. SPS-LEAR Experiments Committee
Publicado: (1997)

Members of the TARC Collaboration pictured with their apparatus
Publicado: (1997)

The TARC Experiment at CERN: Modern Alchemy
por: Revol, Jean-Pierre
Publicado: (2017)

Epithelial Fli1 deficiency drives systemic autoimmunity and fibrosis: Possible roles in scleroderma
por: Takahashi, Takehiro, et al.
Publicado: (2017)

Analytical Performance of a Novel Latex Turbidimetric Immunoassay, “Nanopia TARC”, for TARC/CCL17 Measurement: A Retrospective Observational Study
por: Yamashita, Keita, et al.
Publicado: (2023)

Fli1-haploinsufficient dermal fibroblasts promote skin-localized transdifferentiation of Th2-like regulatory T cells
por: Saigusa, Ryosuke, et al.
Publicado: (2018)

Subcorneal Pustular Dermatosis Exhibiting a High Serum TARC/CCL17 Level
por: Ono, Sachiko, et al.
Publicado: (2013)

Determination of the impurity content of the lead assembly for the TARC experiment
por: Embid, M, et al.
Publicado: (1997)

Interleukin-4 induction of the CC chemokine TARC (CCL17) in murine macrophages is mediated by multiple STAT6 sites in the TARC gene promoter
por: Liddiard, Kate, et al.
Publicado: (2006)

Serum cold-inducible RNA-binding protein levels as a potential biomarker for systemic sclerosis-associated interstitial lung disease
por: Omori, Issei, et al.
Publicado: (2023)

Determination of the beam geometry in the fast extraction mode for the TARC experiment
por: Embid, M, et al.
Publicado: (1997)

Determination of the beam characteristics in the slow extraction mode in the TARC experiment
por: Abánades, A, et al.
Publicado: (1997)

A Blood-Based Screening Tool for Alzheimer's Disease That Spans Serum and Plasma: Findings from TARC and ADNI
por: O'Bryant, Sid E., et al.
Publicado: (2011)

Blood‐circulating EV‐miRNAs, serum TARC, and quantitative FDG‐PET features in classical Hodgkin lymphoma
por: Drees, Esther E. E., et al.
Publicado: (2022)

Update on geometric details of the lead assembly and of the experimental area for the TARC experiment
por: Revol, Jean-Pierre
Publicado: (1996)

CCL17/TARC and CCR4 expression in Merkel cell carcinoma
por: Rasheed, Kashif, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8ng1ot10rajg5e68lqnofjkd12